Dell Technologies Inc. (NYSE: DELL): What EMC’s $984.3 m Air Force award means for defense IT strategy
Read More Pharma Industry News Galecto Biotech secures €79m in Series C funding to advance idiopathic pulmonary fibrosis treatment Galecto Biotech, a Denmark-based pharmaceutical company specializing in galectin modulators for severe diseases like idiopathic pulmonary fibrosis (IPF)… bypharmanewsdailyOctober 27, 2018